Your email has been added to our waiting list and we will send an invite to you as soon as possible. Thank you for your patience.
In the meantime, if you happen to run a blog, our newly launched Blog Enhancement Suite can utilize the immense power of community to help you get more audience, engagement, content, and revenue with your own embeddable community! It will breathe new life into your blog and can automate many of the tedious tasks that come with the territory, so you can focus more on what matters most... writing.
Help spread the word about Snapzu:
Let others know about Snapzu by tweeting about us. We appreciate every mention!
Chinese Covid-19 vaccine candidate 'triggers antibody response'
A Covid-19 vaccine candidate being developed in China has been found to be safe and to trigger an antibody response, early results have shown. Researchers said those aged 60 and over were slower to respond to the BBIBP-CorV vaccine, but they said it was "encouraging" that the vaccine did trigger such a response. They also found antibody levels to be lower in those aged 60 to 80 years, compared with those aged 18 to 59.